Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fastenal

80.19
-1.2500-1.53%
Post-market: 80.17-0.0600-0.07%19:20 EDT
Volume:4.07M
Turnover:328.41M
Market Cap:46.00B
PE:40.09
High:82.40
Open:82.12
Low:79.79
Close:81.44
Loading ...

Morgan Stanley Keeps Their Hold Rating on Fastenal Company (FAST)

TIPRANKS
·
09 Apr

Samsung Ads and Magnite Deepen Partnership to Enhance Audience Addressability in Streaming TV

GlobeNewswire
·
09 Apr

Glo Fiber Expands Lightning Fast Fiber Optic Internet in York County, PA

GlobeNewswire
·
09 Apr

Fast Retailing Expected to Post Lower Second-Quarter Net Profit -- Earnings Preview

Dow Jones
·
09 Apr

Fastenal Co. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
09 Apr

Trader Eugene: The recent structural decline of active developers is concerning, causing the crypto market to be stuck in a short-term loop situation.

Blockbeats
·
09 Apr

Fastenal Gears Up to Report Q1 Earnings: Things to Keep in Mind

Zacks
·
08 Apr

Insights Into Fastenal (FAST) Q1: Wall Street Projections for Key Metrics

Zacks
·
08 Apr

FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug

Zacks
·
08 Apr

Table: Young Fast Optoelecs Mar Rev NT$108.8M Vs NT$111.3M

Dow Jones
·
08 Apr

Fast approvals open door for Aurum to explore West African tenement

The Sydney Morning Herald
·
08 Apr

Sheng Tang Holdings Limited (HKG:8305) May Have Run Too Fast Too Soon With Recent 27% Price Plummet

Simply Wall St.
·
08 Apr

Fastenal Co. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
08 Apr

Allogene Gets FDA Fast Track Designations for ALLO-329 in Autoimmune Diseases

MT Newswires Live
·
07 Apr

The Hackett Group: 89% of Executives Fast-Tracking Gen AI to Drive Enterprise Performance

Business Wire
·
07 Apr

Press Release: NextTrip Acquires JOURNY TV Channel, Expanding Its FAST Media Footprint

Dow Jones
·
07 Apr

Allogene Therapeutics granted three Fast Track Designations for ALLO-329

TIPRANKS
·
07 Apr

Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma

GlobeNewswire
·
07 Apr

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Apr

Santana Minerals Delays Submission of Planned Fast-Track Approvals Application for New Zealand Gold Project

MT Newswires Live
·
07 Apr